z-logo
Premium
A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis
Author(s) -
Naik Haley,
Lockwood Stephen,
Saavedra Arturo
Publication year - 2017
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12986
Subject(s) - medicine , toxic epidermal necrolysis , cd8 , stage (stratigraphy) , graft versus host disease , pathology , erythroderma , retrospective cohort study , dermatology , gastroenterology , disease , immunology , immune system , biology , paleontology
Background Stage 4 skin graft‐versus‐host disease (GVHD) is associated with poor prognosis and high mortality rates. Clinical and histologic similarities with toxic epidermal necrolysis (TEN) make it difficult to distinguish between these 2 life‐threatening conditions. Methods A retrospective cohort study was conducted from a tertiary referral center. Skin biopsies were obtained from 11 patients who developed stage 4 skin GVHD and 11 patients who developed TEN between 2005 and 2012. The CD8+/CD4+ T lymphocyte ratios were assessed in lesional skin specimens. Results Average CD8+and CD4+ cell counts co‐expressing CD3 were 126.29 (range 86.42‐173.06) and 84.60 (29.87‐197.20) for stage 4 skin GVHD patients, and 61.97 (45.79‐146.67) and 7.65 (0.00‐39.50) for TEN patients, respectively. Immunohistochemical studies of stage 4 skin GVHD and TEN skin demonstrated average CD8+/CD4+ ratios of 1.78 (range 0.69‐3.09) and 7.33 (1.16‐12.3), respectively ( P = .013). Conclusions Stage 4 skin GVHD and TEN are processes with cytotoxic profiles. TEN is notable for a greater relative depletion of CD4+ T lymphocytes compared with stage 4 skin GVHD, while stage 4 skin GVHD tends to be more inflammatory than TEN. These data suggest an immunohistologic method by which these 2 entities may be distinguished.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here